Search Results

You are looking at 121 - 130 of 171 items for :

  • Refine by Access: All x
Clear All
Full access

Rondi M. Kauffmann, Leanne Goldstein, Emily Marcinkowski, George Somlo, Yuan Yuan, Philip H.G. Ituarte, Laura Kruper, Leslie Taylor, and Courtney Vito

survival than DCIS. In addition, medical conditions that may preclude the use of anti-e therapy, including deep venous thrombosis (DVT), postmenopausal bleeding, obesity, and endometrial cancer, are more common in the elderly and limit the use of

Full access

Thanh H. Dellinger, Amy A. Hakim, Stephen J. Lee, Mark T. Wakabayashi, Robert J. Morgan, and Ernest S. Han

transmitted diseases, and immunosuppression, whereas in older patients with dermatosis-related vulvar cancer, obesity, diabetes mellitus, and hypertension are frequently present. The clinical presentation in most patients includes vulvar pruritus or a self

Full access

Karen E. Kinahan, Sheetal Kircher, Jessica Altman, Alfred Rademaker, John M. Salsman, Aarati Didwania, Bridget O'Brien, Alpa C. Patel, and Stacy D. Sanford

clinical outcomes and most literature to date is descriptive. EMRs are being used for prescribing medications using clinical decision supports. 18 Other examples include use of BPAs to alert practitioners to order vaccines, refer for obesity counseling

Full access

Alok A. Khorana

, pulmonary disease, renal disease, and obesity. 4 Cancer patients with a prior history of VTE have a 6- to 7-fold increased risk of developing VTE compared with those with no history of VTE. 5 The primary site of cancer is an especially important risk

Full access

Emily J. Guerard, Allison M. Deal, YunKyung Chang, Grant R. Williams, Kirsten A. Nyrop, Mackenzi Pergolotti, Hyman B. Muss, Hanna K. Sanoff, and Jennifer L. Lund

– 739 . 24. Bylow K Hemmerich J Mohile SG . Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case-control study . Urology 2011 ; 77 : 934

Full access

Sarah Asad, Carlos H. Barcenas, Richard J. Bleicher, Adam L. Cohen, Sara H. Javid, Ellis G. Levine, Nancy U. Lin, Beverly Moy, Joyce Niland, Antonio C. Wolff, Michael J. Hassett, and Daniel G. Stover

the Carolina Breast Cancer Study . JAMA 2006 ; 295 : 2492 – 2502 . 10.1001/jama.295.21.2492 16757721 34. Brewster AM , Etzel C , Zhou R , The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National

Full access

NCCN Guidelines® Insights: Palliative Care, Version 2.2021

Featured Updates to the NCCN Guidelines

Maria Dans, Jean S. Kutner, Rajiv Agarwal, Justin N. Baker, Jessica R. Bauman, Anna C. Beck, Toby C. Campbell, Elise C. Carey, Amy A. Case, Shalini Dalal, Danielle J. Doberman, Andrew S. Epstein, Leslie Fecher, Joshua Jones, Jennifer Kapo, Richard T. Lee, Elizabeth T. Loggers, Susan McCammon, William Mitchell, Adeboye B. Ogunseitan, Diane G. Portman, Kavitha Ramchandran, Linda Sutton, Jennifer Temel, Melissa L. Teply, Stephanie Y. Terauchi, Jane Thomas, Anne M. Walling, Finly Zachariah, Mary Anne Bergman, Ndiya Ogba, and Mallory Campbell

, Macdonald N , Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index . J Clin Oncol 2013 ; 31 : 1539 – 1547 . 10.1200/JCO.2012.45.2722 23530101 44. Dy SM

Full access

Terrell Johnson, Michelle McMurry-Heath, Ted Okon, David Rubin, and Robert W. Carlson

reflecting the presence of comorbidities such as hypertension, diabetes, or obesity observed an average decline in TEP of $344 per episode. 16 Looking ahead, CMMI sees opportunities to use these findings to improve future innovation. One question CMMI will

Full access

William J. Gradishar, Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Matthew Goetz, Lori J. Goldstein, Clifford A. Hudis, Steven J. Isakoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena Moran, Sameer A. Patel, Lori J. Pierce, Elizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda Telli, John H. Ward, Dorothy A. Shead, and Rashmi Kumar

experience of the reconstruction team. Smoking and obesity increase the risk of complications for all types of breast reconstruction, whether with implant or flap. 114 – 118 Smoking and obesity are therefore considered relative contraindications to breast

Full access

William J. Gradishar, Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Matthew Goetz, Lori J. Goldstein, Clifford A. Hudis, Steven J. Isakoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena Moran, Sameer A. Patel, Lori J. Pierce, Elizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda Telli, John H. Ward, Dorothy A. Shead, and Rashmi Kumar

-H]. The decision regarding type of reconstruction includes patient preference, body habitus, smoking history, comorbidities, plans for irradiation, and expertise and experience of the reconstruction team. Smoking and obesity increase the risk of